Complex-formation reactions of the L-cysteine-derived ligands (alpha)N-acetyl-S-methylene-(2'-pyridine)-L-cysteine (py-CH(2)-accys) and (alpha)N-acetyl-S-ethylene-2-(2'-pyridine)-L-cysteine (py-C(2)H(4)-accys) with [Pt(en)(H(2)O)(2)](2+) and [Pd(en)(H(2)O)(2)](2+) were investigated structurally by NMR spectroscopy and kinetically by UV-vis and stopped-flow spectrophotometry. The complexes [Pt(en)(py-CH(2)-accys-S,N)](NO(3))(2) (1) and [Pt(en)(py-C(2)H(4)-accys-S,N)](NO(3))(2) (2) were isolated and purified by reversed-phase HPLC. NMR spectroscopy revealed an S-thioether, N-pyridyl chelation mode with five- and six-membered chelate rings for 1 and 2 and their Pd(II) analogues 3 and 4. The amino acid functional group is not involved in coordination. Comparison of the second-order rate constants for the complex-formation reactions resulted in k(Pd(II))/k(Pt(II)) ratios of 3.7 x 10(4) for py-CH(2)-accys and 2.4 x 10(4) for py-C(2)H(4)-accys. In the presence of excess ligand, the trans effect of the Pd-coordinated sulfur donor induced labilization of the coordinated en ligand with successive displacement to give [Pd(py-CH(2)-accys)(2)] and [Pd(py-C(2)H(4)-accys)(2)]. The displacement reactions were shown to be in accordance with a preequilibrium behavior consisting of reversible formation of the ring-opened intermediate followed by successive irreversible ring closure. The results are discussed in reference to available literature data for related systems.
No takes yet. Share an insight, caveat, or question.
Rau et al. (1998) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: